(RTTNews) - Shares of NeuroMetrix, Inc. (NURO) are trading up nearly 34% on Wednesday morning on no stock-specific news.
NURO is currently trading at $1.55, up $0.39 or 33.62%, on the Nasdaq.
Founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology, NeuroMetrix is a commercial stage, bioelectrical and digital medicine company that addresses chronic health conditions including chronic pain and diabetes.
NeuroMetrix's lead product is Quell, an over-the-counter wearable therapeutic device for chronic pain. The company also markets DPNCheck, a rapid point-of-care test for diabetic neuropathy.
Meanwhile, most of the stocks on Wall Street are down on Wednesday, reflecting the continued negative impact of coronavirus pandemic on the global economy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
